List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Intravitreal Injectable Product Introduction
1.2 Market by Drug
1.2.1 Global Intravitreal Injectable Market Size Growth Rate by Drug, 2017 VS 2021 VS 2028
1.2.2 Anti-VEGF
1.2.3 Steroids
1.2.4 Others
1.3 Market by Disease
1.3.1 Global Intravitreal Injectable Market Size Growth Rate by Disease, 2017 VS 2021 VS 2028
1.3.2 Macular Degeneration
1.3.3 Macular Edema
1.3.4 Uveitis
1.3.5 Retinal Vein Occlusion
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Intravitreal Injectable Sales Estimates and Forecasts 2017-2028
2.2 Global Intravitreal Injectable Revenue Estimates and Forecasts 2017-2028
2.3 Global Intravitreal Injectable Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Intravitreal Injectable Sales by Region
2.4.1 Global Intravitreal Injectable Sales by Region (2017-2022)
2.4.2 Global Sales Intravitreal Injectable by Region (2023-2028)
2.5 Global Intravitreal Injectable Revenue by Region
2.5.1 Global Intravitreal Injectable Revenue by Region (2017-2022)
2.5.2 Global Intravitreal Injectable Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Intravitreal Injectable Sales by Manufacturers
3.1.1 Global Top Intravitreal Injectable Manufacturers by Sales (2017-2022)
3.1.2 Global Intravitreal Injectable Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intravitreal Injectable in 2021
3.2 Global Intravitreal Injectable Revenue by Manufacturers
3.2.1 Global Intravitreal Injectable Revenue by Manufacturers (2017-2022)
3.2.2 Global Intravitreal Injectable Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Intravitreal Injectable Revenue in 2021
3.3 Global Intravitreal Injectable Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Intravitreal Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Intravitreal Injectable Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Drug
4.1 Global Intravitreal Injectable Sales by Drug
4.1.1 Global Intravitreal Injectable Historical Sales by Drug (2017-2022)
4.1.2 Global Intravitreal Injectable Forecasted Sales by Drug (2023-2028)
4.1.3 Global Intravitreal Injectable Sales Market Share by Drug (2017-2028)
4.2 Global Intravitreal Injectable Revenue by Drug
4.2.1 Global Intravitreal Injectable Historical Revenue by Drug (2017-2022)
4.2.2 Global Intravitreal Injectable Forecasted Revenue by Drug (2023-2028)
4.2.3 Global Intravitreal Injectable Revenue Market Share by Drug (2017-2028)
4.3 Global Intravitreal Injectable Price by Drug
4.3.1 Global Intravitreal Injectable Price by Drug (2017-2022)
4.3.2 Global Intravitreal Injectable Price Forecast by Drug (2023-2028)
5 Market Size by Disease
5.1 Global Intravitreal Injectable Sales by Disease
5.1.1 Global Intravitreal Injectable Historical Sales by Disease (2017-2022)
5.1.2 Global Intravitreal Injectable Forecasted Sales by Disease (2023-2028)
5.1.3 Global Intravitreal Injectable Sales Market Share by Disease (2017-2028)
5.2 Global Intravitreal Injectable Revenue by Disease
5.2.1 Global Intravitreal Injectable Historical Revenue by Disease (2017-2022)
5.2.2 Global Intravitreal Injectable Forecasted Revenue by Disease (2023-2028)
5.2.3 Global Intravitreal Injectable Revenue Market Share by Disease (2017-2028)
5.3 Global Intravitreal Injectable Price by Disease
5.3.1 Global Intravitreal Injectable Price by Disease (2017-2022)
5.3.2 Global Intravitreal Injectable Price Forecast by Disease (2023-2028)
6 North America
6.1 North America Intravitreal Injectable Market Size by Drug
6.1.1 North America Intravitreal Injectable Sales by Drug (2017-2028)
6.1.2 North America Intravitreal Injectable Revenue by Drug (2017-2028)
6.2 North America Intravitreal Injectable Market Size by Disease
6.2.1 North America Intravitreal Injectable Sales by Disease (2017-2028)
6.2.2 North America Intravitreal Injectable Revenue by Disease (2017-2028)
6.3 North America Intravitreal Injectable Market Size by Country
6.3.1 North America Intravitreal Injectable Sales by Country (2017-2028)
6.3.2 North America Intravitreal Injectable Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Intravitreal Injectable Market Size by Drug
7.1.1 Europe Intravitreal Injectable Sales by Drug (2017-2028)
7.1.2 Europe Intravitreal Injectable Revenue by Drug (2017-2028)
7.2 Europe Intravitreal Injectable Market Size by Disease
7.2.1 Europe Intravitreal Injectable Sales by Disease (2017-2028)
7.2.2 Europe Intravitreal Injectable Revenue by Disease (2017-2028)
7.3 Europe Intravitreal Injectable Market Size by Country
7.3.1 Europe Intravitreal Injectable Sales by Country (2017-2028)
7.3.2 Europe Intravitreal Injectable Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Intravitreal Injectable Market Size by Drug
8.1.1 Asia Pacific Intravitreal Injectable Sales by Drug (2017-2028)
8.1.2 Asia Pacific Intravitreal Injectable Revenue by Drug (2017-2028)
8.2 Asia Pacific Intravitreal Injectable Market Size by Disease
8.2.1 Asia Pacific Intravitreal Injectable Sales by Disease (2017-2028)
8.2.2 Asia Pacific Intravitreal Injectable Revenue by Disease (2017-2028)
8.3 Asia Pacific Intravitreal Injectable Market Size by Region
8.3.1 Asia Pacific Intravitreal Injectable Sales by Region (2017-2028)
8.3.2 Asia Pacific Intravitreal Injectable Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Intravitreal Injectable Market Size by Drug
9.1.1 Latin America Intravitreal Injectable Sales by Drug (2017-2028)
9.1.2 Latin America Intravitreal Injectable Revenue by Drug (2017-2028)
9.2 Latin America Intravitreal Injectable Market Size by Disease
9.2.1 Latin America Intravitreal Injectable Sales by Disease (2017-2028)
9.2.2 Latin America Intravitreal Injectable Revenue by Disease (2017-2028)
9.3 Latin America Intravitreal Injectable Market Size by Country
9.3.1 Latin America Intravitreal Injectable Sales by Country (2017-2028)
9.3.2 Latin America Intravitreal Injectable Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Intravitreal Injectable Market Size by Drug
10.1.1 Middle East and Africa Intravitreal Injectable Sales by Drug (2017-2028)
10.1.2 Middle East and Africa Intravitreal Injectable Revenue by Drug (2017-2028)
10.2 Middle East and Africa Intravitreal Injectable Market Size by Disease
10.2.1 Middle East and Africa Intravitreal Injectable Sales by Disease (2017-2028)
10.2.2 Middle East and Africa Intravitreal Injectable Revenue by Disease (2017-2028)
10.3 Middle East and Africa Intravitreal Injectable Market Size by Country
10.3.1 Middle East and Africa Intravitreal Injectable Sales by Country (2017-2028)
10.3.2 Middle East and Africa Intravitreal Injectable Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Regeneron Pharmaceuticals (Eylea)
11.1.1 Regeneron Pharmaceuticals (Eylea) Corporation Information
11.1.2 Regeneron Pharmaceuticals (Eylea) Overview
11.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Regeneron Pharmaceuticals (Eylea) Recent Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Overview
11.2.3 Allergan Intravitreal Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Allergan Intravitreal Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allergan Recent Developments
11.3 EyePoint Pharmaceuticals
11.3.1 EyePoint Pharmaceuticals Corporation Information
11.3.2 EyePoint Pharmaceuticals Overview
11.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 EyePoint Pharmaceuticals Intravitreal Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 EyePoint Pharmaceuticals Recent Developments
11.4 Genentech
11.4.1 Genentech Corporation Information
11.4.2 Genentech Overview
11.4.3 Genentech Intravitreal Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Genentech Intravitreal Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Genentech Recent Developments
11.5 Kanghong Pharmaceutical
11.5.1 Kanghong Pharmaceutical Corporation Information
11.5.2 Kanghong Pharmaceutical Overview
11.5.3 Kanghong Pharmaceutical Intravitreal Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Kanghong Pharmaceutical Intravitreal Injectable Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Kanghong Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Intravitreal Injectable Industry Chain Analysis
12.2 Intravitreal Injectable Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intravitreal Injectable Production Mode & Process
12.4 Intravitreal Injectable Sales and Marketing
12.4.1 Intravitreal Injectable Sales Channels
12.4.2 Intravitreal Injectable Distributors
12.5 Intravitreal Injectable Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Intravitreal Injectable Industry Trends
13.2 Intravitreal Injectable Market Drivers
13.3 Intravitreal Injectable Market Challenges
13.4 Intravitreal Injectable Market Restraints
14 Key Findings in The Global Intravitreal Injectable Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
